Cargando…
Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units
OBJECTIVE: Clinical Pharmacy Services (CPS) are considered standard of care and is endorsed by the Joint Commission International, the American Academy of Pediatrics, and the American College of Clinical Pharmacy. In Brazil, single experiences have been discreetly arising and the importance of these...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade de Pediatria de São Paulo
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176057/ https://www.ncbi.nlm.nih.gov/pubmed/27578187 http://dx.doi.org/10.1016/j.rppede.2016.04.001 |
_version_ | 1782484757822570496 |
---|---|
author | Okumura, Lucas Miyake da Silva, Daniella Matsubara Comarella, Larissa |
author_facet | Okumura, Lucas Miyake da Silva, Daniella Matsubara Comarella, Larissa |
author_sort | Okumura, Lucas Miyake |
collection | PubMed |
description | OBJECTIVE: Clinical Pharmacy Services (CPS) are considered standard of care and is endorsed by the Joint Commission International, the American Academy of Pediatrics, and the American College of Clinical Pharmacy. In Brazil, single experiences have been discreetly arising and the importance of these services to children and adolescents care has led to interesting results, but certainly are under reported. This short report aims to discuss the effect of implementing a bedside CPS at a Brazilian Pediatric Intensive Care Unit (PICU). METHODS: This is a cross-sectional study conducted in a 12 bed PICU community hospital, from Campo Largo/Brazil. Subjects with<18 years old admitted to PICU were included for descriptive analysis if received a CPS intervention. RESULTS: Of 53 patients accompanied, we detected 141 preventable drug-related problems (DRPs) which were solved within clinicians (89% acceptance of all interventions). The most common interventions performed to improve drug therapy included: preventing incompatible intravenous solutions (21%) and a composite of inadequate doses (17% due to low, high and non-optimized doses). Among the top ten medications associated with DRPs, five were antimicrobials. By analyzing the correlation between DRPs and PICU length of stay, we found that 74% of all variations on length of stay were associated with the number of DRPs. CONCLUSIONS: Adverse drug reactions due to avoidable DRPs can be prevented by CPS in a multifaceted collaboration with other health care professionals, who should attempt to use active and evidence-based strategies to reduce morbidity related to medications. |
format | Online Article Text |
id | pubmed-5176057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Sociedade de Pediatria de São Paulo |
record_format | MEDLINE/PubMed |
spelling | pubmed-51760572017-01-04 Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units Okumura, Lucas Miyake da Silva, Daniella Matsubara Comarella, Larissa Rev Paul Pediatr Original Articles OBJECTIVE: Clinical Pharmacy Services (CPS) are considered standard of care and is endorsed by the Joint Commission International, the American Academy of Pediatrics, and the American College of Clinical Pharmacy. In Brazil, single experiences have been discreetly arising and the importance of these services to children and adolescents care has led to interesting results, but certainly are under reported. This short report aims to discuss the effect of implementing a bedside CPS at a Brazilian Pediatric Intensive Care Unit (PICU). METHODS: This is a cross-sectional study conducted in a 12 bed PICU community hospital, from Campo Largo/Brazil. Subjects with<18 years old admitted to PICU were included for descriptive analysis if received a CPS intervention. RESULTS: Of 53 patients accompanied, we detected 141 preventable drug-related problems (DRPs) which were solved within clinicians (89% acceptance of all interventions). The most common interventions performed to improve drug therapy included: preventing incompatible intravenous solutions (21%) and a composite of inadequate doses (17% due to low, high and non-optimized doses). Among the top ten medications associated with DRPs, five were antimicrobials. By analyzing the correlation between DRPs and PICU length of stay, we found that 74% of all variations on length of stay were associated with the number of DRPs. CONCLUSIONS: Adverse drug reactions due to avoidable DRPs can be prevented by CPS in a multifaceted collaboration with other health care professionals, who should attempt to use active and evidence-based strategies to reduce morbidity related to medications. Sociedade de Pediatria de São Paulo 2016 /pmc/articles/PMC5176057/ /pubmed/27578187 http://dx.doi.org/10.1016/j.rppede.2016.04.001 Text en © 2016 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Okumura, Lucas Miyake da Silva, Daniella Matsubara Comarella, Larissa Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units |
title | Relation between safe use of medicines and Clinical Pharmacy Services at
Pediatric Intensive Care Units |
title_full | Relation between safe use of medicines and Clinical Pharmacy Services at
Pediatric Intensive Care Units |
title_fullStr | Relation between safe use of medicines and Clinical Pharmacy Services at
Pediatric Intensive Care Units |
title_full_unstemmed | Relation between safe use of medicines and Clinical Pharmacy Services at
Pediatric Intensive Care Units |
title_short | Relation between safe use of medicines and Clinical Pharmacy Services at
Pediatric Intensive Care Units |
title_sort | relation between safe use of medicines and clinical pharmacy services at
pediatric intensive care units |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176057/ https://www.ncbi.nlm.nih.gov/pubmed/27578187 http://dx.doi.org/10.1016/j.rppede.2016.04.001 |
work_keys_str_mv | AT okumuralucasmiyake relationbetweensafeuseofmedicinesandclinicalpharmacyservicesatpediatricintensivecareunits AT dasilvadaniellamatsubara relationbetweensafeuseofmedicinesandclinicalpharmacyservicesatpediatricintensivecareunits AT comarellalarissa relationbetweensafeuseofmedicinesandclinicalpharmacyservicesatpediatricintensivecareunits |